TOANO, Va., Nov. 7, 2019 /PRNewswire/ -- Navy veteran Jessenia Smith and her husband Truitt experienced the healing nature of caring for horses at a Wounded Warrior Project® (WWP) equine therapy workshop. Their love for animals enhanced the workshop's impact and helped them interact with other veterans.

LONG ISLAND CITY, N.Y., Nov. 7, 2019 /PRNewswire/ -- Schweiger Dermatology Group ("SDG"), the largest dermatology provider in the Northeast, announced they were named to the Crain's New York Business 2019 Fast 50 list. To be considered for the Fast 50, companies had to be at least four years old, generate at least $10 million in

MONTREAL, Nov. 7, 2019 /PRNewswire/ - Optina Diagnostics, a world leading company in retinal imaging and artificial intelligence with a vision to change mindsets when it comes to brain health, and Wagner Macula Retina Center, a center of excellence for ophthalmology, are entering into a collaboration agreement to conduct a clinical study for the advancement of Optin

CONCORD, N.H., Nov. 7, 2019 /PRNewswire/ -- The Anticancer Lifestyle Foundation (ALF) and The Geneia Institute announce the creation of the online, on-demand version of the Anticancer Lifestyle Program (ACLP). The ACLP is a comprehensive, evidence-based lifestyle transformation course for cancer survivors and those who seek to reduce their risk of cancer.

MINNEAPOLIS, Nov. 7, 2019 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO; OTCQX: VREOF), a leading physician-led, science-focused, multi-state cannabis company, today announced that it has named Bruce Linton to the role of Executive Chairman. As Executive Chairman, Mr. Linton will be

SAN FRANCISCO, Nov. 7, 2019 /PRNewswire/ -- Fifty years after the first-ever White House Conference on Food, Nutrition & Health – which led to the creation of the Nutrition Facts label on food packaging – digital health innovator, AeBeZe Labs, wants people to better understand a different kind of nutrition. Specifically, the company is focused on the

ANDOVER, Mass., Nov. 7, 2019 /PRNewswire/ -- Capsule Technologies announced the commercial release of Capsule Neuron 3, a significantly enhanced iteration of the company's flagship cl

- Gilead to reduce momelotinib commercial royalty rates in exchange for equity in Sierra -- Amendments become effective upon Sierra Oncology closing a qualified financing - VANCOUVER, Nov. 7, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization

VANCOUVER, Nov. 7, 2019 /PRNewswire/ - Sierra Oncology, Inc. (Nasdaq: SRRA), a late-stage drug development company focused on the development and commercialization of momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with a potentially differentiated therapeutic profile for the treatment of myelofibrosis, today announced the pricing of an underwritten public offering

NEW YORK, Nov. 7, 2019 /PRNewswire/ -- AiCure, recognized as one of the world's 100 most innovative artificial intelligence companies, announced a Series C fundraising round totaling $24.5 million. The financing was led by Palisades Growth Capital (PGC) with new investors from Singtel Innov8 (Innov8), Asahi Kasei Corporation, Accelmed Growth